FDA.reportPublic FDA data

Duvyzat 8.86 MG/mL Oral Suspension

RxCUI
2678900
RxNorm name
Duvyzat 8.86 MG/mL Oral Suspension
Display name
Duvyzat 8.86 MG/mL Oral Suspension
Full name
Duvyzat 8.86 MG/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DUVYZATGIVINOSTATItalfarmaco SPA1a28a3db-7880-4ac2-a2f2-2b4e362aafb62024-11-21Warnings, Adverse reactionsExact identifier
rxcui: 2678900

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1a28a3db-7880-4ac2-a2f2-2b4e362aafb6Duvyzat 8.86 MG/mL Oral Suspension [PSN] · givinostat 8.86 MG/ML Oral Suspension [Duvyzat] [SBD] · Duvyzat 8.86 MG/mL (equivalent to givinostat HCl monohydrate) Oral Suspension [SY] · Duvyzat 8.86 MG/mL Oral Suspension [SY]42These highlights do not include all the information needed to use DUVYZAT safely and effectively. See full prescribing information for DUVYZAT. DUVYZAT (givinostat) oral suspension Initial U.S. Approval: 202420241121